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ABSTRACT 
 
Orbital exenteration is a surgical procedure used in the management of advanced malignant 
disease.
 
It is used to treat both invasive and recurrent orbital tumours
.  
This disfiguring 
surgical procedure involves removal of orbital contents, including the periorbita, eyelids and 
sometimes varying amounts of the surrounding peri-orbital skin. Studies from developing 
countries have shown that Squamous Cell Carcinoma (SCC) is the predominant indication for 
orbital exenteration. The high prevalence of conjunctival SCC in Sub-Saharan African has a 
strong link to ultraviolet radiation, Human Immunodeficiency Virus infection (HIV) and 
Human Papilloma Virus (HPV) infection. As the burden of disease increases, it becomes 
crucial for clinicians in Africa and other developing countries to understand how these 
Tumours’ behave, and how HIV potentially impacts on the disease. Such an evaluation may 
potentially benefit current management strategies. Furthermore, the need to effectively and 
appropriately manage such a neoplastic burden in a developing world setting with limited 
resources is of fundamental importance. This study reports an experience of orbital 
exenteration at this institution. 
OBJECTIVES:   Firstly to describe all orbital tumours exenterated at St. John Eye Hospital over 
a four year period in terms of histopathology, tumour behaviour and completeness of 
excision. Secondly to determine if a link to HIV infection exists.  
DESIGN AND METHOD: A retrospective analysis of electronic records from the National 
Health Laboratory System (NHLS) was conducted on all the patients who underwent an 
orbital exenteration at St. John Eye Hospital from the 1
st
 of July 2008 to 30
th
 of June 2012 
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RESULTS: The total number of patients who underwent an orbital exenteration in the stated 
time period was 84. Twenty eight patients were excluded from the study and the final sample 
size was therefore 56.  
The average age of presentation was 42 and the overall female to male ratio was 1:1.07.  Four 
patients underwent a lid sparing procedure while the remaining 52 patients had a total 
exenteration. The tissue of origin was conjunctival in 75% of cases.  The most frequent 
presenting complaint and indication for surgery was an invasive conjunctival tumour in 56% 
of patients, followed by a gross orbital tumour in 27% of patients. Squamous cell carcinoma 
of the conjunctiva was the most frequently diagnosed tumour. Out of 56 specimens, 
51(91.06%) were of the squamous cell type, 1.79% High Grade Squamous Dysplasia, 3.57% 
Leiomyosarcoma, 1.79% Metastatic Breast Adenocarcinoma and 1.79% Spindle Cell 
Melanoma.   
Histological grading of all specimens showed 69.64% of these tumours were moderately 
differentiated, 21.43% poorly differentiated and 8.93% were unknown.  
The distribution of the tumour staging in the sample group, according to the TNM 
Classification was as follows, 51.79%- Stage 4,  19.64% -Stage 3, 10.71%-Stage 2, 1.79% 
Stage 1, 1.79% Stage Tumour In Situ and 14.28% unknown.  
Regarding completeness of excision, 53.57% of tumours had positive tumour margins and 
42.86% showed complete excision with clear margins, 3.57% were unknown. Only 28(50%) 
patients had a HIV result on electronic record. CD4 counts were available for 23 out of the 28 
patients. 
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CHAPTER 1 
1.1) INTRODUCTION 
Squamous cell carcinoma (SCC) is the most common malignancy of the conjunctiva in Sub-
Saharan Africa and worldwide.
1,2,3
 It forms part of a spectrum of disease referred to as Ocular 
Surface Squamous Cell Neoplasia (OSSN), extending from simple dysplasia, to carcinoma in 
situ and ultimately to invasive carcinoma.
4,5,6
 
Invasive squamous cell carcinoma is distinguished histo-pathologically, by breachment of the 
epithelial basement membrane and invasion of the stroma by tumour cells.
 1, 3 
Human 
Immunodeficiency Virus (HIV) is a well-recognized risk factor for the development of 
invasive conjunctival SCC. The association was first reported in the early 1990’s in sub-
Saharan Africa.
4-8
 HIV infection increases the risk of SCC 10 fold.
9
  
While HIV infection in itself is thought to have oncogenic effects,
 9
 the high prevalence of 
conjunctival squamous cell carcinoma in Sub-Saharan Africa is complex and likely to be 
multifactoral.
1-4, 7, 11, 14
High ultraviolet light-B (UVB) exposure and Human Papilloma Virus 
(HPV) infection, especially the type 16 and 18 infections are compounding factors involved 
in the complex carcinogenic process.
2, 3, 5, 7, 9, 11, 14 
 
P-53 mutations are a form of UVB light induced damage identified with increased frequency 
in HIV positive patients with conjunctival squamous cell carcinoma. This gene is responsible 
for a protein thought to play a critical role in tumour suppression and cell cycle control.
5 
Presuming HIV and HPV are in fact linked, it may be that HIV infection disrupts the immune 
system’s control over HPV’s oncogenic effects.12 The exact interaction of HIV, sunlight 
exposure and HPV infection in the tumour’s pathogenesis, remains unclear.6, 7, 12, 14   
14 
 
As the burden of this and other Acquired Immune Deficiency Syndrome (AIDS) - related 
neoplasm’s increase 2, 6-8, 11, 13 it becomes crucial for clinicians in Africa and other developing 
countries to understand how these tumours behave, and how HIV potentially impacts on this 
behaviour. Such an evaluation may potentially benefit current management strategies. 
Furthermore, the need to effectively and appropriately manage such a neoplastic burden in 
the context of limited resources is of fundamental importance.  
It is in this context that the following study will analyse invasive orbital tumours exenterated 
at St. John Eye Hospital, looking specifically at the indications for surgery, the invasiveness 
of the tumour and how HIV infection may be related to these two features.  
1.2) LITERATURE REVIEW 
The World Health Organization (WHO) estimates that since 1993 there are more than 40 
million adults and children living with HIV/AIDS worldwide.  Sub-Saharan Africa is home to 
more than two thirds of all these individuals living with HIV.
6, 11, 14
 
This has had a dramatic effect on the profile of cancer and in this, the fourth decade of the 
pandemic, it is evident that the burden of neoplastic diseases is increasing in developing 
countries.
6,8,12 
Furthermore, in a post-HAART (Highly Active Antiretroviral Therapy) era, the 
lengthening of life expectancy has also meant an increased risk of developing both AIDS and 
NON-AIDS defining cancers.
14
 The loss of tumour surveillance in HIV infected individuals 
may be important in the development of cancer. Increased overall survival allows more time 
for the tumour to evolve and grow.
10
  
Squamous cell carcinoma of the conjunctiva is a well-recognized AIDS associated cancer in 
Sub-Saharan Africa
1-3, 6, 8, 9, 11, 14
 with a natural history that is unique to this region.
6, 11, 13, 14 
The increase in the epidemic of conjunctival SCC has furthermore coincided with the HIV 
epidemic.
9, 11, 13, 14 
Almost 80% of patients diagnosed with conjunctival squamous cell 
15 
 
carcinoma are found to be HIV positive
11
 and this may be the first presenting manifestation 
of HIV infection.
 5
  
In HIV infected individuals conjunctival squamous cell carcinoma is more malignant, 
aggressive 
1, 3, 11
 and more likely to metastasize and recur.
3, 7, 11
 Furthermore, patients in 
developing countries tend to present at a younger age, and at more advanced stages of 
neoplastic disease due to the financial burdens of a low income society. 
1-3, 6, 7
  
Several studies from Africa revealed that a proportion of these patients with invasive 
conjunctival squamous cell carcinoma presented for the first time with an orbital mass 
1, 3, 6, 7 
requiring an orbital exenteration as the primary modality of treatment with or without 
chemotherapy.
1-3, 6, 7 
Furthermore patients undergoing orbital exenteration in developing 
countries like Africa and India are doing so for neglected advanced ocular surface and peri-
orbital malignant disease 
1-3, 7, 15, 16
 
Studies from tropical regions seem to all show that SCC is the predominant indication for 
orbital exenteration.
1-3, 6-8,15,16 
 There is some variation  from different case studies regarding 
the indication for surgery and some reports from western populations have found Basal Cell 
Carcinoma (BCC)
 
 to be the major indication for orbital exenteration.
18,19
 A large study 
conducted in Turkey examined 429 cases found SCC to be the single most common  
indication for orbital exenteration.
20
 Recent studies emerging from the developed world have 
also reported SCC as the most frequently exenterated tumour.
21 
Orbital Exenteration is a surgical strategy used in the management of advanced malignant 
disease.
15- 19 
It is used to treat both invasive and recurrent orbital masses.
15-18 
The surgical 
procedure involves removal of orbital contents, including the periorbita, eyelids and 
sometimes varying amounts of the surrounding peri-orbital skin.
15-19 
 Orbital exenteration 
may be classified into a total or subtotal procedure, the latter involves preservation of the 
16 
 
eyelids i.e. lid sparing exenteration to yield a cosmetically more acceptable result.
15
 Tumour 
eradication however must always take priority over cosmesis.
19
 When clear surgical margins 
are achieved, the recurrence rate can be as low as 7-10%.
17 
Orbital exenteration is a step in the sequential management plan that includes surgical cure 
and cosmetic rehabilitation.
15-19
The risk of recurrence is dependent on multiple factors. This 
includes completeness of surgical excision, the type, stage and aggressiveness of the tumour 
which, as mentioned may be related to HIV infection. 
3, 11, 15, 16, 17
 Surgeons fearing recurrence 
may opt to simply leave the orbit to granulate or delay orbital reconstruction aimed at 
improving cosmesis with the use of a split skin graft or local flap.
15,17,18 
Orbital reconstruction 
is usually reserved for less advanced tumours and when the surgeon is confident about tissue 
clearance.
15
 
 
Greater understanding of these factors discussed above, particularly in a setting like St. John 
Eye Hospital (SJEH) with limited resources, may give the surgeon greater insight into the 
effectiveness of the current procedure as well as the follow up of these patients once the 
tumour is excised.
14  
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1.3) RESEARCH AIM 
This study aimed to describe all orbital tumours exenterated over a four year period at SJEH. 
1.4) RESEARCH QUESTIONS 
 The following research questions were posed: 
-What is the main indication for exenteration of orbital tumours at SJEH? 
-Is this surgical procedure effectively removing the tumour? 
 The subsequent hypotheses were: 
-Squamous cell carcinoma, with a strong association to HIV infection, is primarily the 
indication for orbital exenteration at SJEH. 
-Orbital exenteration is an effective surgical cure. 
1.5) RESEARCH OBJECTIVES 
 To investigate the histo-pathology of orbital tumours exenterated at SJEH over the 
stated time period. 
 To investigate the aggressiveness of the tumour excised. 
 To document the presence of HIV infection in these patients and the degree of 
immune suppression as reflected by the CD4 count.   
 To investigate the completeness of surgical excision of the tumour. 
1.6) OUTCOME MEASURES 
 Histo-pathological diagnosis of the orbital tumour 
 Presence or absence of clear tumour-free surgical margins 
 Staging of the tumour 
 HIV status and CD4 count 
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CHAPTER 2 
2.1)  STUDY DESIGN 
A retrospective cross-sectional study was conducted. Electronic records from the National 
Health Laboratory System (NHLS) were reviewed of all the patients who underwent an 
orbital exenteration at St. John Eye Hospital (SJEH) from the 1
st
 of July 2008 to the 30
th
 of 
June 2012.  
2.2) DATA COLLECTION 
Data collection commenced upon obtaining ethics approval from the Human Research Ethics 
Committee (Appendix A) and consent from the Head of Pathology at the University of 
Witwatersrand, to access and reviews the histo-pathology reports from the NHLS. Consent 
was granted from the chief executive officer at Chris Hani Baragwanath Academic Hospital 
(CHBAH) to use the hospitals theatre records at SJEH. Theatre records were used to find the 
name and hospital number of the patients who underwent surgery in the stated time period 
and it was this hospital number that was then used to electronically access the histo-pathology 
reports.  
2.3) INCLUSION CRITERIA 
All patients who had an orbital exenteration performed at SJEH from the 1
st
 of July 2008 to 
30
th
 of June 2012 with a formal histo-pathology report on record was included in the study. 
2.4) EXCLUSION CRITERIA 
Any patient who did not have a formal histo-pathology report recorded by the NHLS was 
excluded from the study.  
19 
 
2.5) DATA MANAGEMENT  
Data from the records of patients meeting the inclusion criteria for the study were captured on 
a Microsoft Word Excel spread sheet by the primary researcher. Each patient was allocated a 
serial number to maintain privacy throughout data analysis. Information regarding all patient 
names and hospital numbers were available only to the primary researcher. The following 
information was recorded: 
 NUMBER OF CASES PER ANNUM: An audit was done of the total number of surgical 
cases done each year.  
 AGE AND SEX: The age of the patient at the time of the surgery as recorded in the 
histopathology report.  Gender was assigned as male or female. 
 LATERALITY: The eye involved by the tumour; either left or right was recorded. 
 THE TYPE OF ORBITAL EXENTERATION: The procedure was recorded as either a 
total or lid-sparing exenteration. 
 INDICATION FOR SURGERY: The type of gross anatomical tumour each patient 
presented with was recorded. If this was not specified in the patient’s report, the data 
entry was captured as “not specified.” 
 TISSUE OF ORIGIN: The tissue from which tumour cells were seen to arise was 
recorded. If no comment was recorded in the pathologist’s report regarding the tissue 
of origin, a data entry of “not specified” was recorded. 
 HISTOLOGICAL DIAGNOSIS: This was recorded as a final assessment of the diseased 
eye’s tissue following histological analysis by the pathologist. 
 HISTOLOGICAL GRADE:  Histological grade or differentiation describes how closely 
the tumour resembles the tissue of origin. (Appendix C.) This was recorded as well 
differentiated, moderately differentiated or poorly differentiated. If no comment on 
20 
 
histological grading was included in the report the data entry was captured as “not 
specified.” 
 STAGING: The “Tumour, Node, Metastases” (TNM) classification (Appendix B) 
was used to stage the tumour following histo-pathological analysis. The staging done 
by the pathologist and included in the histopathology report was restricted to the “T 
category” only.  In keeping with current protocols lymph nodes were not routinely 
biopsied and sent with the primary excised specimens to the pathologist for analysis. 
No radiological tests were sent to the pathologist either to assist with comprehensive 
staging of the tumour. A complete TNM staging could therefore not be done by the 
pathologist at the time of histological and pathological diagnosis. When lymph nodes 
in the “N category” could not be assessed, the notation “Nx” was added to the final 
staging. Similarly when metastases could not be assessed in the “M category” a 
notation “Mx” was recorded. If the pathologist did not include a comment on staging 
in the histopathology report, the data entry “not specified” was recorded.  
 TUMOUR-FREE RESECTION MARGINS: Surgical margins of the tumour were 
recorded in the histopathology report as being either tumour free or as being involved 
by the tumour. The latter would imply that the tumour was not completely excised. 
The data entry for a tumour-free resection margin was entered as either Yes or No. 
 HIV STATUS: The hospital number of every patient was used to check the electronic 
NHLS database to determine if an HIV blood test had been performed and its result.  
The result was recorded as either reactive (positive) or non-reactive (negative). HIV 
testing is a voluntary process in South Africa and this precluded testing in some 
instances. If no HIV test record was available, the data entry was captured as 
“unknown.”   
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2.6) DATA ANALYSIS 
A descriptive analysis of the data was conducted.  Continuous variables were described using 
the mean, median, standard deviation, and an interquartile range, while categorical variables 
were described by their frequency distributions. 
2.7) LIMITATIONS 
The retrospective nature of the study meant that data collection was limited by the availability 
of information in each patient’s electronic record. Furthermore, since HIV testing was a 
voluntary procedure and by some patients refusing testing, the number of HIV infected 
patients undergoing orbital exenteration may have been underestimated. Another limitation is 
that the TNM staging could not be assessed accurately due to the limited availability of data. 
2.8) STAFF AND ADMINISTRATION 
The study was conducted by Dr P.Y Raman (Ophthalmology registrar) and supervised by 
Prof. GD McLaren (Head of Department at St John Eye Hospital). 
2.9) ETHICAL CONSIDERATIONS 
The protocol was submitted to the Wits Human Research Ethics Committee and upon review 
a clearance certificate was received. (Appendix A). 
Patient confidentiality regarding all patients’ names, hospital numbers, blood results and 
histopathology reports, was maintained throughout data collection and analysis by allocation 
of a serial number to each patient. Only this serial number was used during data capture.   
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CHAPTER 3 
3.1)  TOTAL NUMBER OF CASES EXENTERATED CASES 
The total number of patients who underwent an orbital exenteration in the stated time period 
was 84 cases. The fewest cases (17) were recorded in year 1 (1 July 2008-30 June 2009) and 
the most cases (25) were recorded in year 4 (1 July 2011- 30 June 2012). 
The total number of cases performed each year in the stated 4 year period is illustrated in 
Figure 1. 
 
Figure 1.The distribution of orbital exenteration patients over the 4 year study period  
 
56 of the 84 patients had complete data. Every patient in the study had only one eye involved 
by the disease process.  
If large amounts of relevant data were missing or if there was no electronic information 
recorded on the NHLS database for a patient, the patient was excluded from the study. This 
was a standardized process applied without bias to any patient record obtained from SJEH 
theatre book in the stated time period. When electronic records were inadequate or not found, 
the hard copy of that patient’s file was not used. The reason for this is that many patients at 
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SJEH take their files home with them or lose their files along the course of their follow up, 
leaving the filing system in the hospital inevitably incomplete and unhelpful in the process of 
data collection. 
The sample size therefore comprised 56 patients. 
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3.2)  AGE AT THE TIME OF SURGERY 
The univariate statistics for age at the time of surgery is represented by univariate statistics in    
Table 1. 
Table 1:  Age distribution 
Mean 42.2 
Standard deviation 10.04 
Median 41 
Interquartile range 39-45.3 
Range 26-80 
  
3.3) SEX 
The study population comprised 48% males and 52% females. The overall ratio of female to 
male in the study was 1:1.07. 
3.4) LATERALITY 
43% of tumours involved the right eye and 57% involved the left eye 
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3.5.) TYPE OF PROCEDURE PERFORMED  
 The tumour was assessed by the operating surgeon preoperatively by clinical examination 
and a CAT scan of the involved orbit done. If the tumour was grossly invasive and seen to 
involve the lids, a total exenteration was performed which involved removal of the entire 
orbital contents including the lids. When the tumour was confined to the globe and orbit only, 
the lids were spared in the procedure leaving a cosmetically better result.   
52 patients (93%) had a total exenteration performed and 4 patients (7%) had a lid sparing 
procedure.  
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3.6) INDICATION FOR ORBITAL EXENTERATION 
The clinical indications in terms of gross anatomical presentation are illustrated in Figure 2. 
An invasive conjunctival tumour (55%) and gross orbital tumour (27%) were the presenting 
complaint and indication for surgery in the majority of patients.  
 
Figure 2.Clinical indication for performing surgery, expressed as a percentage of all tumours 
analysed in the study group 
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3.7) TISSUE OF ORIGIN 
A summary of all anatomical tissues detected, from which tumours were seen to arise is 
illustrated in Figure 3. A total of 42 (75%) specimens revealed that the tissue from which 
malignant tumour cells were seen to arise, was the conjunctiva. 
 
Figure 3.Tissue of origin of each tumour represented as a percentage of all tumours analysed 
in the study group. 
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3.8) HISTOPATHOLOGICAL DIAGNOSIS 
The distribution of the histo-pathological diagnoses made for all tumours analysed is 
illustrated in Figure 4. 
Squamous cell carcinoma of the conjunctiva was the most frequently diagnosed tumour. Out 
of 56 specimens, 51(91.06%) were of the squamous cell type. Further analysis of the 51 
squamous cell carcinoma tumours, revealed that 29 (51.78%) were non- keratinising on 
histopathological examination and 22 (39.28%) were keratinising. 
 
Figure 4.Histopathological diagnosis represented as a percentage of all tumours excised in the 
study group 
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3.9) HISTOLOGICAL GRADE 
The frequency of the histopathological grade of each tumour is illustrated in Figure 5. 
How closely the tumour resembles the tissue from which it arises constitutes differentiation.  
5 specimens (8.93%) had no comment on histological grade included in their pathology 
reports overall, the majority of specimens analysed were moderately differentiated (69.64%). 
 
 
Figure 5.Histological grade of each tumour represented as a percentage of all tumours 
analysed in the patient study group 
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3.10) TUMOUR STAGING 
The frequency of each stage (TNM Staging system) of tumour exenterated in the patient 
study group is illustrated in Figure 6.  
The histopathology report of 48 patients included tumour staging. 29 (51.79%) specimens 
analysed were Stage 4 and 11 (19.64%) that were Stage 3. 
 
Figure 6.The staging of each tumour analysed and expressed as a percentage of the total 
number of cases in the study group 
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3.11) COMPLETENESS OF EXCISION 
The incidence of complete excision and attainment of tumour-free surgical margins is 
illustrated in Figure 7. 
Out of 56 specimens, 30(53.57%) showed incomplete excision; evident by the presence of 
tumour cells at the resection margins, 24(42.86%) specimens revealed tumour-free resection 
margins, i.e. complete excision of the tumour and 2 specimens (3.57%) were not specified. 
 
Figure 7.The completeness of excision of each tumour exenterated expressed as a percentage 
of total number of tumours exenterated in the study group 
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3.12) RETROVIRAL STATUS 
The HIV status of each patient in the study group is represented in Figure 8. 
HIV testing was performed using an Enzyme-linked immunosorbent assay (ELISA). This is 
the first test used to detect infection with HIV. If antibodies to HIV are detected 
(reactive/positive), the test will be repeated to confirm the diagnosis. 
 Only 28(50%) patients had an HIV result on electronic record. CD4 counts were available 
for 23 out of these 28 patients. The average CD4 count was 157. 
 
Figure 8.HIV blood results of the study group 
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CHAPTER 4 
4.1) DISCUSSION 
The total amount of orbital exenteration surgeries performed at SJEH in the stated 4 year 
study period was 89. The largest study that was done on the procedure, originated in a study 
from Turkey.
20 
The study reviewed 429 cases over a 30 year period and remains the largest 
collection of data found on orbital exenteration. 
 When compared to more recent reports from the western world were data was also collected 
over a much longer period (up to 14 years), the number of cases done at SJEH remains much 
higher.
17,19,21
  Similar studies in developing countries
2, 3, 15, 16
 also show a higher number of 
cases when compared to data from first-world countries.
17, 19
  
Interestingly, the number of cases of orbital exenterations performed at SJEH is still much 
higher even in comparison with similar studies in other parts of Africa which were also done 
over a 4 year period or even longer.
3,15
 SJEH is a part of Chris Hani Baragwanath Academic 
Hospital (CHBAH), the largest hospital in Africa. Furthermore, the high burden of disease 
seen at SJEH could be attributable to the eye clinic being the largest eye care referral centre 
in Africa.  
The high number of patients with incomplete data meant that out of the total number of 89 
patients who had undergone exenteration, only 56 patients could  be analysed and provide 
information  that would address the study aims and objectives.  
The reason that data was incomplete on electronic record or entirely missing is not clear. 
Furthermore when electronic data was not available the paper filing system at SJEH could not 
be relied on because this too was incomplete. The reason for this was thought to be due to 
some patients keeping their files with them and not leaving them at the hospital after their 
34 
 
appointments. Furthermore patient follow up was generally poor and it was not possible to 
track down all patient files on patient follow up visits in the period allocated for data 
collection.   
 Poor follow up due to socio-economic circumstances and incomplete data in is a well 
described challenge for developing countries trying to collect data for research purposes.
3.15,16
   
The distribution of orbital exenteration surgeries over the 4 year study shows that since 2008, 
this procedure is being performed with increased frequency at SJEH.  
The mean age at presentation was 42.16 years, with a range from 26 to 80 years. This is much 
younger than studies that have emerged from the developed world where the average age of 
presentation is in the 6
th
 decade.
17, 19, 21
 SCC however, even when involving the lid, seems to 
present at a younger age.
21
  
Younger age of presentation in this study was suspected to be related to a positive HIV status. 
Several studies in Africa have shown that patients with OSSN who have a reactive HIV status 
present at a younger age and at a more advanced stage in the cancer.
1-3, 6, 7
Such conclusions 
however could not be drawn in this study due to an inadequacy of data regarding retroviral 
status. There was little disparity regarding gender and the overall female to male ratio was 
1:1.07. 
A conventional orbital exenteration was performed in 52 patients. This involved removing 
the eyelids and total orbital and periorbital contents. The remaining 4 patients had a lid-
sparing procedure.  All operations were performed under general anaesthetic.  
With regards to surgery of invasive tumours, reports on how aggressive local surgical 
resection should be, remains controversial.
17
What is clear is that when a tumour is locally 
invasive and a surgical cure is thought to be possible with complete excision, a total 
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exenteration with removal of the entire orbital contents and periorbita is preferred. When 
clear surgical margins are achieved, total exenteration can result in the recurrence rate being 
as low as 7-10%.
17 
While patients are thought to have a better cosmetic results and easier facial rehabilitation 
with a lid sparing procedure, cosmesis will be sacrificed over the control of local disease.
17-19,
 
21 
The fact that most of the study patients at SJEH had a total exenteration, may reflect the 
advanced stage of disease with which these patients presented. 
 The historical records at SJEH showed a distribution in the use lid-sparing procedures 
extending from 2009 to 2012 which provides evidence that when appropriate, this procedure 
was used. This is in keeping with publications at the time advocating a more individualized 
and tissue sparing approach.
17-19, 21 
The fact that a “total” type of exenteration surgery was 
performed in the majority of cases despite a trend to a more conservative approach reflected 
in the literature, suggests that the tendency to perform more extensive local resection at SJEH 
was indicated in light of more advanced clinical disease presenting in these patients rather 
than surgeon preference.  
All patients in the study had a neoplastic indication for exenteration. The majority of patients 
presented with either a conjunctival neoplastic mass (55%). The second commonest 
presentation was an orbital neoplastic mass (27%).  Only 4% of patients presented with a lid 
neoplasm. This is in contrast to similar studies from western countries
17, 19, 21
 and even a 
study from India
16
, where most exenteration procedures were performed for tumours 
originating from the eyelids.   
Furthermore 51 of 54 (91%) of all tumours showed a histopathological diagnosis of SCC 
arising from the conjunctiva. This type of malignancy is known to be the commonest 
carcinoma of the conjunctiva across the globe.
1,2,3
 The results of this study are in keeping 
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with reports  from other developing countries in Africa which showed that the most common 
indication for exenteration was a malignant orbital mass due to an invasive conjunctival 
SCC.
2,3,6-7,15
 Reports from other cases series in different parts of the world do show some 
variation in terms of the indication for orbital exenteration, with reports that Basal Cell 
Carcinoma (BCC) was the main indication for surgery emerging from western countries
19, 21
 
and  Sebaceous Gland Carcinoma (SGC) being more common in Indian patients.
16
 These 
results may reflect a demographic and geographic pattern in the  prevalence of certain 
tumours. 
 
This study found none of the tumours to be due to BCC or SGC.  Interestingly 2 patients 
were found to have Leiomyosarcoma, 1 patient had a Spindle Cell Melanoma and 1 patient 
had metastatic breast Adenocarcinoma. The rare incidence of orbital metastases found in this 
study group is in keeping with other case reports that have found orbital metastases to 
account for a very small percentage of all orbital tumours.
23.24
 Carcinoma of the breast has 
furthermore, been found to be the most common primary site giving rise to orbital 
metastases.
23
  
Regarding the two cases of Leiomyosarcoma, both were primary tumours arising within the 
orbital and periorbital region. The one patient was 35 years old and had a reactive retroviral 
status. The CD4 count was 77.  The second patient was 46 years old and had no record of 
retroviral status on the NHLS.  
 Leiomyosarcoma rarely occurs in the orbit and there are few publications documenting such 
cases.
24
 Leiomyosarcoma is a malignant soft tissue tumour with features of smooth muscle 
differentiation and is the most prevalent type of sarcoma. Liposarcomas and 
Leiomyosarcomas occur most frequently in adults.
24, 25
The tumour may be of a primary or 
metastatic origin.  In the case of a primary tumour, cancerous cells are thought to arise from 
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vascular smooth muscle.
24
 Secondary tumours have been identified to originate from primary 
tumours in the uterus, gastrointestinal tract and soft tissues. 
24 
Haematogenous spread from 
primary orbital Leiomyosarcoma results in distant metastatic disease to mainly the liver and 
lungs.
24 
 
 While being the most common form of sarcoma, its occurrence in the orbit, primary or 
metastatic, remains rare.
24
The two cases in this study affirm this. The overall incidence of 
sarcoma in this report is 4%.  
Research suggests that Leiomyosarcoma is the most commonly reported sarcoma in HIV 
infected individuals and occurs with increased frequency in HIV positive children and young 
adults. The patients typically have low CD4 counts.
25
Both patients in this study were under 
the age of 50. The one patient whom was known to be HIV infected, showed severe levels of 
immune suppression, and this supports existing research.
25 
While certain sarcomas such as Kaposi’s sarcoma are clearly linked to immune deficiency, 
the contribution of a compromised immune system to the occurrence of other sarcomas such 
as Leiomyosarcoma remains unclear.
25
  
The solitary patient, whose tumour was found on histopathology to be Spindle Cell 
Melanoma, was a 40 year old male of African descent. His HIV status was reactive. No CD4 
count was available on electronic records. 
 This is an extremely rare occurrence and there is a paucity of data on uveal melanoma in this 
racial group.
26,27
 A case report on an African-American patient with uveal melanoma noted 
that the incidence of uveal melanoma in Caucasians to be eight times higher than that of 
African-Americans. Phillpotts et al in O’Keeffee N. et al stated that these tumours, in a Non-
Caucasian ethnic group, tend to be larger, show signs of necrosis, inflammation and 
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secondary glaucoma.
26
Choroidal Melanoma has also shown to present at a younger age in 
African/Asian patients than was described by the Collaborative Ocular Melanoma study 
where the mean age was 60 years. 
26
  
These features were also found to be present in this study. The patient in this study was 
young, similar to a study in India were the average age of presentation 45.94 years.
26,27 
The 
tumour  was shown on histological examination, to occupy the entire globe and showed signs 
of central necrosis, although there was no significant inflammation present. The tumour was 
furthermore of the mixed cell type which is keeping with studies that have described it as the 
most common subtype.
26
  
Despite such variations in different case series regarding the incidence of tumours, the most 
recent reports including this study, seem to reflect SCC is the most common indication for 
orbital exenteration globally.
17, 21
 
Ackuaku-Dogbe reported in a study from Ghana that although conjunctival SCC is not 
typically aggressive, there is growing evidence supporting an aggressive type of neoplasm in 
tropical and subtropical regions that also affect younger patients. A study from Australia, 
which also has a harsher climate with high degrees of ultraviolet radiation, also reported SCC 
of the ocular surface to have a higher incidence of scleral invasion (30%) and orbital invasion 
(15%) compared to previous data that reported the malignancy to be of a low grade and 
intraocular invasion by SCC to be rare.
21 
Regarding the histopathological classification, 71% of patients had moderately differentiated 
squamous cell carcinoma and 21% were poorly differentiated tumours, the remaining 8 % 
was unknown. 52% of tumours were at least a stage 4 tumour (orbital invasion)
 
according to 
the TNM classification.
22
 The majority of tumours exenterated in this study were therefore 
both aggressive and invasive.  Neither lymph nodes nor distant metastatic disease could be 
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assessed by the pathologist as routine sentinel lymph node (SLN) biopsy is not performed at 
the time of surgery. Metastatic spread to lymphatic nodes is not common in conjunctival 
SCC, and SLN biopsy is usually reserved for tumours known to be highly metastatic like 
sebaceous gland carcinoma and melanoma.
22
 It has however, been suggested that it may be 
valuable to also consider a sentinel lymph node biopsy in patients with advanced conjunctival 
SCC stage 3 or 4 disease.
22 
  
A substantial proportion of the patients at SJEH had stage 3 disease or a more advanced stage 
(72%) at the time of surgery and this may support the implementation of SLN biopsy at the 
time of primary surgery to detect early metastatic disease.  
The current protocol at SJEH involves a preoperative clinical examination and Computerized 
Tomography (CT) scan of the brain and orbits. CT scan best demonstrates bony erosion while 
Magnetic Resonance Imaging (MRI) would be better at detecting soft tissue involvement in 
the orbit.
17
 Due to the cost of MRI scans this is reserved for select cases and is not routinely 
done at SJEH as part of the patients metastatic workup. Blood tests are also done which 
include a baseline blood work up comprising a full blood count and renal function blood test. 
Pre-test counselling and testing for HIV may also be conducted if the patient is agreeable.   
During surgery the surgeon will record whether or not bony erosion and sinus spread was 
observed and a record will be made in the patients file. Frozen section analysis has been 
suggested as being useful in such cases 
17 
but is not available at SJEH and SLN biopsy is not 
routinely done.   
If bony erosion and sinus invasion is noted, patients are referred with the final histopathology 
report of the excised tumour and a post-operative CT scan to the radiation-oncology 
department at the Charlotte Maxeke Johannesburg Academic Hospital. The follow up visits 
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of patients especially once referred for radiation is extremely poor. This may be due to patient 
morbidity and socio-economic factors.  
Further studies focussing on the reason for demise in patients undergoing orbital exenteration 
would be most useful in evaluating the true benefit of frozen section analysis intra-
operatively and SLN biopsy in this population.  
The trend of poor follow up of patients at SJEH is much like other African countries and is 
mainly due to socioeconomic reasons.
2, 3, 16
 Furthermore the burden of disease in these 
patients is often compounded by other diseases like HIV and Tuberculosis and patients may 
be too sick to travel long distances using public transport to get to hospital. In a setting like 
SJEH which faces these challenges of a developing country, it remains unknown in this study 
population what the mortality seen in orbital exenteration patients is truly related to.  
Regarding the success of surgical excision, more than half of all tumours excised showed 
incomplete removal on histopathological examination.  54% of patients had tumour- positive 
margins, 43% had clear margins and an inconclusive result remained in 3% of specimens. 
These results are inferior to similar case series that reported tumour-free margins in 62%-
68% of cases.
22
The reason for this may be due to the aggressive nature of the tumours 
described and the advanced stage at presentation. 
Solar radiation, HPV and HIV are established risk factors for the development of conjunctival 
SCC
2, 3, 5, 7, 9, 11, 14
 and this could be the reason for the high prevalence of this cancer in both 
this study and similar studies in sub-Saharan Africa as well as countries with a similar 
climate like India and Austraila.
16, 21
  
While the high prevalence of HIV in Sub-Saharan Africa could be predisposing these patients 
to conjunctival squamous cell carcinoma, no definitive link between HIV and OSSN could be 
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established in this report as mentioned earlier, because only 50% of patients had a record of 
their status on the NHLS. 
The reason for such incomplete data regarding HIV results may be due to several reasons.  
HIV testing is a voluntary procedure and following pre-test counselling patients may have 
declined to do an ELISA blood test. Secondly data may have been lost when the hospital 
changed the electronic lab system in 2013 to a more updated software system (LABtrack). 
Blood results that may have been reflected on the old system were, following the change, no 
longer available on the new electronic system during the period of data collection.  
Finally some patients may have been tested in peripheral clinics and already knew their HIV 
status was reactive, therefore the only blood test on the labs electronic system was a CD4 
count.  
This is a challenge that continues at SJEH and the paucity of such important information 
highlights the need for more emphasis being placed on pre-test counselling and a high index 
of suspicion among health care workers when dealing with patients with OSSN. A study in 
Malawi suggested from the findings, that OSSN may be both the initial presenting and only 
observable sign of infection with HIV and subsequently recommended that every patient who 
was younger than 60, living in an area with high HIV infection rates should strongly be 
advised to have a test performed. 
5 
A surgical procedure in a patient who is HIV-infected has an impact on both the individual 
and the surgeon. It is important to know a patients viral load and CD4 count preoperatively to 
make a sound surgical risk assessment for the individual patient. Evidence has shown in some 
cases, that patients with low CD4 counts have poorer surgical outcomes and while not 
conclusively so, there is also data suggesting that patients with viral suppression may do 
better postoperatively.
28
 Furthermore, a surgeon’s risk of exposure is much lower if an HIV-
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infected patient is on treatment and has undetectable viral loads.
28
 This evidence only 
reiterates the vital importance of attaining knowledge of a patient’s retroviral status 
preoperatively. 
 
 It may be valuable for the managing doctor to explain to the involved patient if testing is 
refused, that an ELISA can still be done without the result being disclosed to the patient until 
they are ready to be informed.  Only the doctor in charge need know the patients HIV status 
and this can give much guidance in the patients overall best management. Patients may then 
be willing to undergo testing despite being afraid and can be assured they will be getting best 
practice management. A patient coming to terms with their status may entail a stepwise 
process of acceptance. 
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4.2) CONCLUSION 
 
This study presents an analysis of orbital tumours exenterated over a four year period at St 
John Eye Hospital.  Information is provided regarding patient demographics, the indications 
for surgery and histopathology. The data emerging from this study supports evidence from 
other developing African countries that the majority of orbital tumours arise from the 
conjunctiva and are typically invasive, presenting at an advanced stage in the disease course.
2, 
3, 5, 6,7,8,9
 In keeping with these studies, the patients were found to be younger, but no 
association with HIV infection could be definitively established due to the lack of data 
available. More than half of all tumours excised in this study showed incomplete excision 
implying that these patients would need to be referred for radiotherapy. SLN biopsy may 
assist in more efficient post-operative management and support the need for adjuvant therapy 
in patients with metastatic disease.
22 
This study’s experience reflects a high burden of disease in a limited resources setting.  The 
socio-economic challenges facing these patients result in a later clinical presentation as well 
as a poor follow-up after surgery. This is likely to affect their prognosis overall. Educating 
patients who present with conjunctival masses about the seriousness of their condition may 
improve this, as well as advising patients to not delay excision of conjunctival masses and to 
seek immediate medical attention if recurrences occur following excision. 
The fact that the findings of this study closely resemble other case series from other parts of 
Africa that demonstrated a strong association between HIV and conjunctival SCC suggest 
that more efforts need to be made regarding pre-test counselling and HIV testing in this 
facility.
 2,3,5,6,7,8,9
 This information is fundamental in the offering patient’s holistic care. 
Finally attention to data capturing and record keeping as well as advising patients to hand in 
their files at reception after every visit may, moving forward, offer more information 
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regarding patient morbidity and mortality post-operatively. This may lead the way for further 
studies to examine rehabilitation and survival in these patients. 
What was known before? 
Orbital exenteration is performed at SJEH for the treatment of invasive neoplastic orbital 
tumours. HIV testing is not mandatory. Metastatic workup and lymph node biopsy is not 
routinely performed.  
What this study adds? 
Orbital exenteration is being performed with increased frequency at SJEH as the neoplastic 
burden of disease has increased. The most common neoplasm detected on histopathology was 
SCC arising from the conjunctiva. The tumour was found to be aggressive and invasive. The 
findings were in keeping with other developing countries found to have high UV-light 
exposure and a high incidence of HIV. Although no definite association to HIV could be 
established due to insufficient data, in patients who did have a reactive status, their CD4 
count was below 300cells/mm
3
. If these patients were not already on treatment, this would 
warrant initiation of ARVs. Furthermore SCC of the conjunctiva is well defined AIDS-
associated cancer in other parts of Sub-Saharan Africa. The findings of this study have 
similar implications and reinforce the importance of pre-test HIV counselling testing to 
encourage patients to take both an HIV ELISA test and CD4 count.  
More than half of all patients undergoing orbital exenteration for these tumours at SJEH had 
incompletely excised tumours and were at risk of metastatic disease. This may warrant re-
evaluation of the current management protocol to possibly include wider excision margins 
such as a limited ethmoidectomy and sentinel lymph node biopsy at the time of surgery. 
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APPENDIX A  
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APPENDIX B 
Pathological classification (pTNM): Conjunctival carcinoma (McGowan HD. Squamous 
Neoplasia of the Conjunctiva: The New TNM Classification by the American Joint 
Committee on Cancer (AJCC). Ophthalmology Rounds. 2009, 7(1): 130-38E.) 
Primary tumour (pT) 
pTX Primary tumour cannot be assessed 
pT0 No evidence of primary tumour 
pTis Carcinoma in situ 
pT1 Tumour(s) of bulbar conjunctiva, greatest dimension less than 5 mm. 
pT2 Tumour(s) of bulbar conjunctiva, greatest dimension greater than 5 mm. 
pT3 Tumour(s) of conjunctiva invading adjacent structures (excluding the orbit) 
pT4 Tumour invades orbit with or without further extension 
 
Regional lymph nodes (pN) 
pNX Regional lymph nodes cannot be assessed 
pN0 No regional lymph node metastasis 
pN1 Regional lymph node metastasis 
 
Distant metastasis (pM) 
pMX Distant metastasis cannot be assessed 
pM0 No distant metastasis 
pM1 Distant metastasis 
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APPENDIX C 
Histopathological grade: represents the primary tumour (McGowan HD. Squamous 
Neoplasia of the Conjunctiva: The New TNM Classification by the American Joint 
Committee on Cancer (AJCC). Ophthalmology Rounds. 2009, 7(1): 130-38E.) 
 
GX – Grade cannot be assessed 
G1 – Well differentiated 
G2 – Moderately differentiated 
G3 – Poorly differentiated 
G4 – Undifferentiated 
 
 
 
 
 
 
 
 
 
 
 
 
